The ActiPatch® Bioelectric Pain Management Platform from Electrome Corporation is built to meet the requirements of the Health Insurance Portability and Accountability Act (HIPAA), including the Privacy, Security, and Breach Notification Rules.
Electrome acts as a Covered Entity for the patient-facing services we operate directly (such as support for prescription fulfillment of RecoveryRx®) and as a Business Associate when we provide provider services to a healthcare provider, clinic, or health system that is itself a Covered Entity.
All Protected Health Information (PHI) collected through ActiPatch®, Clinical AI Concierge, and connected ActiPatch® / RecoveryRx® session data is encrypted with AES-256 at rest and TLS 1.2+ in transit.
Patient (self-service and clinical tiers), provider, retailer, affiliate, and investor portals are isolated. Only the patient's authorized care team and Electrome staff with a documented need-to-know can access PHI. Self-service wellness data is PII, not PHI.
We maintain signed BAAs with every vendor that may touch PHI on our behalf, including hosting, email, scheduling, analytics, and pharmacy fulfillment partners for RecoveryRx®.
24/7 monitoring, audit logging, and a written incident-response plan. Affected individuals, HHS, and (where required) media are notified within HIPAA Breach Notification Rule timeframes.
If you are a patient of a healthcare provider that uses Clinical AI Concierge, or you receive RecoveryRx® through our platform, you have the following rights regarding your Protected Health Information:
Electrome is actively exploring FIPS 140-3 certified, post-quantum safe cryptography for data-in-motion, targeted for implementation in 2026. FIPS 140-3 is the U.S. federal cryptographic module standard published by the National Institute of Standards and Technology (NIST) and is recognized internationally (via ISO/IEC 19790) as the benchmark for validated cryptographic implementations used by regulated industries, including healthcare.
Today, the vast majority of the world's data-in-motion is protected by AES-based symmetric encryption negotiated through RSA and elliptic-curve (ECDH/ECDSA) key exchange. These public-key schemes are mathematically vulnerable to a sufficiently large, fault-tolerant quantum computer running Shor's algorithm, and symmetric keys face an effective halving of their security margin under Grover's algorithm. This creates a real-world "harvest now, decrypt later" risk: data intercepted today can be stored and decrypted years from now once quantum hardware matures.
The solution we are bringing in goes beyond swapping in NIST's post-quantum primitives (e.g., ML-KEM / ML-DSA, formerly CRYSTALS-Kyber and CRYSTALS-Dilithium). It is engineered so that intercepted ciphertext contains no exploitable mathematical relationship to the underlying plaintext or to the session keys. In practical terms, even stolen traffic cannot be reversed by Shor's, Grover's, or any currently known cryptanalytic attack — and remains resistant to future many-qubit quantum computers — because there is nothing in the captured bytes for those algorithms to solve.
We have already identified the world's leading provider of this technology. A proof-of-concept / pilot deployment is scheduled to go live in our sandbox environment in Q3 2026, ahead of broader rollout across PHI-bearing services.
Healthcare providers, clinics, and health systems subscribing to Clinical AI Concierge are required to execute Electrome's standard BAA before PHI is exchanged. To request a copy of our BAA, contact our Privacy team.
Contact our Privacy Officer for any questions about our HIPAA practices, to request a BAA, or to exercise your rights.